These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12495790)

  • 41. Gender differences in the impact of comprehensive services in substance abuse treatment.
    Marsh JC; Cao D; D'Aunno T
    J Subst Abuse Treat; 2004 Dec; 27(4):289-300. PubMed ID: 15610830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gender and use of substance abuse treatment services.
    Green CA
    Alcohol Res Health; 2006; 29(1):55-62. PubMed ID: 16767855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Women in residential drug treatment: differences by program type and pregnancy.
    Grella CE
    J Health Care Poor Underserved; 1999 May; 10(2):216-29. PubMed ID: 10224827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alcohol dependence and use of treatment services among women in the community.
    Wu LT; Ringwalt CL
    Am J Psychiatry; 2004 Oct; 161(10):1790-7. PubMed ID: 15465975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addiction severity index data from general membership and treatment samples of HMO members. One case of norming the ASI.
    Weisner C; McLellan AT; Hunkeler EM
    J Subst Abuse Treat; 2000 Sep; 19(2):103-9. PubMed ID: 10963921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A search for strategies to engage women in substance abuse treatment.
    Comfort M; Loverro J; Kaltenbach K
    Soc Work Health Care; 2000; 31(4):59-70. PubMed ID: 11140343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Weekly patterns of drug treatment attendance.
    Svikis DS; Pickens RW; Schweitzer W; Johnson E; Haug N
    Am J Public Health; 1999 May; 89(5):752-5. PubMed ID: 10224989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of psychiatric disorders in predicting drug dependence treatment outcomes.
    Compton WM; Cottler LB; Jacobs JL; Ben-Abdallah A; Spitznagel EL
    Am J Psychiatry; 2003 May; 160(5):890-5. PubMed ID: 12727692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of retention in a drug-free unit/substance abuse treatment in prison.
    Casares-López MJ; González-Menéndez A; Festinger DS; Fernández-García P; Fernández-Hermida JR; Secades R; Matejkowski J
    Int J Law Psychiatry; 2013; 36(3-4):264-72. PubMed ID: 23706657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug treatment, health, and social service utilization by substance abusing women from a community-based sample.
    Hansen H; Alegría M; Cabán CA; Peña M; Lai S; Shrout P
    Med Care; 2004 Nov; 42(11):1117-24. PubMed ID: 15586839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychopathology influences treatment retention among drug-dependent women.
    Haller DL; Miles DR; Dawson KS
    J Subst Abuse Treat; 2002 Dec; 23(4):431-6. PubMed ID: 12495807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of health sector market factors and vulnerable group membership on access to alcohol, drug, and mental health care.
    Stockdale SE; Tang L; Zhang L; Belin TR; Wells KB
    Health Serv Res; 2007 Jun; 42(3 Pt 1):1020-41. PubMed ID: 17489902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pilot study of motivation and treatment completion among American Indian adolescents in substance abuse treatment.
    Fickenscher A; Novins DK; Beals J
    Addict Behav; 2006 Aug; 31(8):1402-14. PubMed ID: 16364556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Early drop-outs and retentions in substance abuse outpatient clinics: a cross-sectional comparative study of factors that increase or decrease adherence].
    Calvo F; Carbonell X; Valero R; Costa J; Turró O; Giralt C; Ramírez M
    Aten Primaria; 2018 Oct; 50(8):477-485. PubMed ID: 28843489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of outpatient treatment retention: patient versus substance use characteristics.
    McCaul ME; Svikis DS; Moore RD
    Drug Alcohol Depend; 2001 Mar; 62(1):9-17. PubMed ID: 11173163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Participation in community residential treatment and substance abuse patients' outcomes at discharge.
    Moos RH; King MJ
    J Subst Abuse Treat; 1997; 14(1):71-80. PubMed ID: 9218240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing sex differences on treatment effectiveness from the drug abuse treatment outcome study (DATOS).
    Acharyya S; Zhang H
    Am J Drug Alcohol Abuse; 2003 May; 29(2):415-44. PubMed ID: 12765214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utilization of Substance Abuse Treatment: Gender Differences among Participants in an Aftercare Program.
    Yeom HS
    Soc Work Public Health; 2015; 30(7):578-91. PubMed ID: 26457926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of communication and relationship skills training for men in substance abuse treatment.
    Bartholomew NG; Hiller ML; Knight K; Nucatola DC; Simpson DD
    J Subst Abuse Treat; 2000 Apr; 18(3):217-25. PubMed ID: 10742634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increasing retention of African-American women on welfare in outpatient substance user treatment using low-magnitude incentives.
    Bride BE; Humble MN
    Subst Use Misuse; 2008 Jul; 43(8-9):1016-26. PubMed ID: 18649227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.